GeneCapture, Inc. Market Research Report

Company Overview

Name, Mission of the Company

• Name: GeneCapture, Inc.

• Mission: To bring infection detection out of the lab and directly to the patient at the point of care, even in austere environments. GeneCapture’s proprietary technology aims to transform the identification and treatment of infectious diseases.

Founding Information

• Founded: No information available

• Founders: Dr. Krishnan Chittur

Key People

• CEO: Peggy Sammon (Co-Founder)

• CTO: Dr. Krishnan Chittur (Co-Founder)

• Chief Scientist & PI: Paula Millirons

• COO: Greg Thompson

• Advisors:

• Fran White, MDC Assoc. (Regulatory)

• Nate Ledeboer, PhD (Medical College of Wisconsin)

• Trish Simner, PhD (Johns Hopkins University)

• Chris Doern, PhD (Virginia Commonwealth University)

• Andy Stewart (Dx Consultant Group)

• Scott Powell (Dx Consultant Group)

• Louise O’Keefe, PhD (UAH Clinic Director & College of Nursing)

• Steve Smith, RADM US Navy (ret) (Director of Disaster Planning, SBA)

• Jim Kvach, PhD (Chief Scientist DIA, Armed Forces Medical Intelligence Services)

• John Schmitt, US Army LTC (ret) (Director of AMIIC)

Headquarters

• Location: 601 Genome Way, Huntsville, AL 35806, USA

Number of Employees

• No information available

Revenue

• No information available

What is the Company Known For

• GeneCapture is known for developing a portable technology for rapid pathogen identification and antibiotic susceptibility testing, known as The CAPTURE Platform™.

Products

The CAPTURE Platform™

• High-Level Description:

• A portable diagnostic tool designed for pathogen identification and antibiotic susceptibility testing (AST). It provides actionable answers quickly without the need for lab equipment or refrigeration.

• Key Features:

• Portable Technology: Does not require lab equipment or refrigeration.

• Rapid Results: Reports pathogen identification in one hour and antibiotic susceptibility in another hour.

• Multi-Pathogen Capability: Supports sample-to-answer testing from samples including blood, urine, swab, or saliva.

• Integrated System: Combines raw sample processing, RNA hybridization, and susceptibility testing in a single, low-cost device.

• Room Temperature Storage: Incorporates lyophilized antibiotics stable at room temperatures.

• Versatile Applications: Suitable for use in clinical, community, agricultural, and battlefield environments.

Recent Developments

New Products Launched / New Features Added

• No information is available

Partnerships and Collaborations

• May 2, 2023: Collaboration with Auburn University

• Awarded Matching SBIR Grant from Innovate Alabama to enable remote infection detection for animal and agricultural applications.

Awards and Recognitions

• March 15, 2024: $2.5 Million DoD Award

• May 30, 2023: $1 Million DoD Award

• April 19, 2023: National DoD Award

• August 10, 2021:

• $2.1 Million DoD Contract Award bringing total DoD awards to $5.5 Million.

• December 16, 2020: Defense Health Agency Contract Award

• October 16, 2020: Rapid Pathogen ID Demonstration

• May 18, 2020: Selected into xTechSearch Accelerator

Statements from Leadership

• Peggy Sammon, CEO:

• “We want to make a BIG difference on a global scale. By reducing the time it takes to identify infection and providing an Antimicrobial Susceptibility Test on-site, we will change health care. Antimicrobial drugs are life savers – but only if they are used when needed; otherwise, they weaken our bodies to future threats. We bring fast decision-making directly to the patient. Infections must be treated quickly.”

Conclusion

GeneCapture, Inc. continues to innovate in the field of rapid pathogen detection through its CAPTURE Platform™, which promises to significantly impact healthcare and infection management across various settings. The company collaborates with prominent institutions and has garnered substantial funding and awards from the Department of Defense, underscoring its pivotal role in diagnostic advancements.